Biomarkers in Pain: 2nd Edition
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".
Deadline for manuscript submissions: 30 March 2026 | Viewed by 779
Special Issue Editors
Interests: anesthesiology; biomarkers; coagulation; cytokines; endotoxin; critical care medicine; intensive care; leptin; inflammation; intraosseous; sepsis; SAPS3; shock
Special Issues, Collections and Topics in MDPI journals
Interests: endotoxin; intensive care; acute kidney injury; glomerular filtration rate markers; kidney tubular damage markers; cardiovascular risk markers; neutrophil activation markers; calprotectin
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Acute and chronic pain are two major reasons that patients seek healthcare. Approximately 20% of the world’s population suffers from chronic pain, and in the USA alone, annual economic losses due to chronic pain are estimated to be USD 600 billion. Apart from being a major economic burden for society, chronic pain is also a major cause of decreased quality of life.
Chronic pain is often difficult to treat, and we have few objective measures for evaluating pain levels. Patients in pain therefore often struggle to have their pain problems acknowledged, as pain is a subjective experience that is difficult to verify. During the last decade, biomarkers related to chronic pain have been investigated. The discovery of such markers could not only be used to improve the diagnoses and prognostication of patients with chronic pain, but could also support those who file an insurance claim after an injury. Biomarkers of pain could also be used to distinguish different causes of pain, allowing for an improved selection of treatments. Such markers could also provide pharmaceutical companies with a tool for evaluating pain relief effects in clinical trials.
The focus of this Special Issue of Biomedicines is on the value of biomarkers of pain from a broad perspective.
Biomarkers of pain may be used to identify and quantify pain of various origins in order to facilitate adequate therapeutic interventions. Extensive prescriptions of analgesics, especially opioids, are associated with overdose deaths. Although pain is a subjective experience, the use of determinants of pain as an end point in clinical trials may help to predict the safety as well as the analgesic efficacy of new drugs.
Dr. Mats B. Eriksson
Prof. Dr. Anders O. Larsson
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- analgesia
- biomarker
- CSF
- cytokine
- inflammation
- neuropathy
- neurotransmitter
- pain
- QoL
- sensitization
- sensory
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
Related Special Issue
- Biomarkers in Pain in Biomedicines (8 articles)
